Quantification of Fragments of Human Serum Inter-α-Trypsin Inhibitor Heavy Chain 4 by a Surface-Enhanced Laser Desorption/Ionization-Based Immunoassay
Abstract
Background: Several proteolytically derived fragments from the proline-rich region (PRR) of human inter-α-trypsin inhibitor heavy chain 4 (ITIH4) have been identified by surface-enhanced or matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS or MALDI-TOF-MS) as potential disease markers.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 01, 2006
- Source ID
- 10.1373/clinchem.2005.065722
Entities
People
- C. Nicole Rosenzweig
- Daniel W. Chan
- Eric T Fung
- Jin H Song
- Lori J. Sokoll
- Manisha Patel
- Michael Goggins
- Nam-ho Choi-miura
- Yee Chan-li
- Zhen Zhang
Organizations
- Johns Hopkins School of Medicine
- National Cancer Institute
- National Institutes of Health
- Showa Medical University
- United States Department of Defense